Vol 10, No 4 (2024)
Review paper
Published online: 2024-10-11
The road to a standard medical treatment for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis — a practical guide
DOI: 10.5603/rf.100074
Rheumatology Forum 2024;10(4):176-183.
Abstract
Axial spondyloarthritis affects 0.1% to 1% of the general population, depending on the source. Unfortunately, despite new diagnostic criteria, also adapted to non-radiographic axial spondyloarthritis, and advances in imaging modalities (widespread use of magnetic resonance imaging), the late diagnosis of the disease and, therefore, a delay in starting therapy still pose a serious problem. On average, the time between the first symptoms of the disease and its diagnosis is several years. Patients' access to modern treatment methods is also still delayed. This paper presents a practical guide to both the diagnosis and treatment of axial spondyloarthritis in Poland.
Keywords: ankylosing spondylitisaxial spondyloarthritisbiological treatment
References
- Ehrenfeld M, Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev. 2010; 9(5): A325–A329.
- Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68(6): 777–783.
- Braun J, Baraliakos X, Buehring B, et al. [Epidemiology and prognostic aspects of ankylosing spondylitis]. Radiologe. 2004; 44(3): 209–10, 212.
- Robinson PC, Sengupta R, Siebert S. Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy. Rheumatol Ther. 2019; 6(2): 165–177.
- Poddubnyy D. Challenges in non-radiographic axial spondyloarthritis. Joint Bone Spine. 2023; 90(1): 105468.
- Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018; 30(2): 137–143.
- Sieper J, Poddubnyy D. New evidence on the management of spondyloarthritis. Nat Rev Rheumatol. 2016; 12(5): 282–295.
- Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017; 390(10089): 73–84.
- Burton PR, Clayton DG, Cardon LR, et al. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee, Breast Cancer Susceptibility Collaboration (UK). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007; 39(11): 1329–1337.
- DeLay ML, Turner MJ, Klenk EI, et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009; 60(9): 2633–2643.
- Glatigny S, Fert I, Blaton MA, et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum. 2012; 64(1): 110–120.
- Abe Y, Ohtsuji M, Ohtsuji N, et al. Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model. Mod Rheumatol. 2009; 19(3): 316–322.
- Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012; 18(7): 1069–1076.
- Stolwijk C, van Tubergen A, Castillo-Ortiz JD, et al. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74(1): 65–73.
- Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017; 29(4): 317–322.
- Diekhoff T, Lambert R, Hermann KG. MRI in axial spondyloarthritis: understanding an 'ASAS-positive MRI' and the ASAS classification criteria. Skeletal Radiol. 2022; 51(9): 1721–1730.
- Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011; 63 Suppl 11: S47–S58.
- www.poruszycswiat.pl.
- Ramiro S, Nikiphorou E, Sepriano A, et al. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis. 2023; 82(1): 142–152.
- Samborski W, Sikorska D, Niklas A, et al. NLPZ a powikłania sercowo-naczyniowe i gastroenterologiczne — algorytm wyboru. Forum Reumatologiczne. 2018; 4(3): 143–151.
- Choroby nieonkologiczne. https://www.gov.pl/web/zdrowie/choroby-nieonkologiczne.
